0 |
GLUCOSE TOLERANCE IMPAIRED IN PREGNANCY |
1 |
0.0370 |
1 |
RECTAL INJURY |
3 |
0.0349 |
2 |
PULMONARY HILUM MASS |
3 |
0.0185 |
3 |
EDENTULOUS |
3 |
0.0174 |
4 |
BETA 2 MICROGLOBULIN INCREASED |
3 |
0.0149 |
5 |
ORAL CONTUSION |
2 |
0.0126 |
6 |
DYSKINESIA OESOPHAGEAL |
1 |
0.0122 |
7 |
GASTROENTERITIS RADIATION |
3 |
0.0109 |
8 |
ENTROPION |
1 |
0.0087 |
9 |
IMMUNOGLOBULINS INCREASED |
3 |
0.0085 |
10 |
MONOCLONAL GAMMOPATHY |
3 |
0.0060 |
11 |
PNEUMOTHORAX SPONTANEOUS |
3 |
0.0058 |
12 |
PROTEUS INFECTION |
3 |
0.0057 |
13 |
INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE |
3 |
0.0053 |
14 |
PENILE CURVATURE |
1 |
0.0052 |
15 |
MINERAL DEFICIENCY |
1 |
0.0046 |
16 |
ENTEROCUTANEOUS FISTULA |
3 |
0.0043 |
17 |
HAEMOPHILUS INFECTION |
3 |
0.0042 |
18 |
SUBCUTANEOUS EMPHYSEMA |
3 |
0.0042 |
19 |
AMMONIA ABNORMAL |
1 |
0.0034 |
20 |
FISTULA DISCHARGE |
3 |
0.0030 |
21 |
ORAL SOFT TISSUE DISORDER |
1 |
0.0030 |
22 |
THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0028 |
23 |
ABSCESS ORAL |
3 |
0.0027 |
24 |
INTRAOCULAR LENS IMPLANT |
1 |
0.0026 |
25 |
RHONCHI |
3 |
0.0026 |
26 |
GROIN INFECTION |
1 |
0.0025 |
27 |
CONJUNCTIVITIS INFECTIVE |
1 |
0.0025 |
28 |
PULMONARY VALVE STENOSIS CONGENITAL |
1 |
0.0024 |
29 |
B-CELL LYMPHOMA RECURRENT |
1 |
0.0023 |
30 |
DIAPHRAGMATIC PARALYSIS |
1 |
0.0021 |
31 |
LIP HAEMORRHAGE |
2 |
0.0020 |
32 |
INFECTION IN AN IMMUNOCOMPROMISED HOST |
1 |
0.0020 |
33 |
PLASMACYTOMA |
3 |
0.0020 |
34 |
METHAEMOGLOBINAEMIA |
3 |
0.0020 |
35 |
BRONCHITIS VIRAL |
1 |
0.0019 |
36 |
BRONCHIAL WALL THICKENING |
1 |
0.0018 |
37 |
AORTIC CALCIFICATION |
1 |
0.0017 |
38 |
EMOTIONAL POVERTY |
2 |
0.0016 |
39 |
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME |
1 |
0.0016 |
40 |
PROCTITIS |
3 |
0.0016 |
41 |
VERTEBRAL FORAMINAL STENOSIS |
1 |
0.0015 |
42 |
ALCOHOL POISONING |
3 |
0.0014 |
43 |
INTERVERTEBRAL DISC SPACE NARROWING |
1 |
0.0014 |
44 |
DEAFNESS TRANSITORY |
1 |
0.0014 |
45 |
TRANSPOSITION OF THE GREAT VESSELS |
1 |
0.0013 |
46 |
ANAEMIA OF CHRONIC DISEASE |
1 |
0.0013 |
47 |
MASTICATION DISORDER |
3 |
0.0013 |
48 |
RIGHT VENTRICULAR HYPERTROPHY |
1 |
0.0012 |
49 |
NECK INJURY |
3 |
0.0012 |
50 |
PRODUCT CONTAINER SEAL ISSUE |
1 |
0.0012 |
51 |
CONTRAINDICATED PRODUCT PRESCRIBED |
1 |
0.0011 |
52 |
PAROTITIS |
1 |
0.0011 |
53 |
HYPOVITAMINOSIS |
1 |
0.0010 |
54 |
PRODUCT TAMPERING |
1 |
0.0010 |
55 |
OEDEMA MOUTH |
3 |
0.0010 |
56 |
APPLICATION SITE DISCHARGE |
1 |
0.0010 |
57 |
APHTHOUS STOMATITIS |
2 |
0.0009 |
58 |
LEFT VENTRICULAR HYPERTROPHY |
3 |
0.0009 |
59 |
BILIARY DILATATION |
1 |
0.0008 |
60 |
MOUTH INJURY |
1 |
0.0008 |
61 |
INFUSION SITE BRUISING |
1 |
0.0008 |
62 |
COSTOCHONDRITIS |
1 |
0.0008 |
63 |
SPINAL DEFORMITY |
1 |
0.0007 |
64 |
TONGUE DISCOMFORT |
2 |
0.0007 |
65 |
HYPOAESTHESIA ORAL |
8 |
0.0007 |
66 |
GINGIVAL PAIN |
4 |
0.0006 |
67 |
TOOTHACHE |
9 |
0.0006 |
68 |
OSTEOLYSIS |
1 |
0.0006 |
69 |
COLONOSCOPY |
1 |
0.0006 |
70 |
SKIN ABRASION |
2 |
0.0006 |
71 |
INGUINAL HERNIA |
3 |
0.0006 |
72 |
SKIN INDURATION |
1 |
0.0006 |
73 |
PROTHROMBIN TIME PROLONGED |
3 |
0.0005 |
74 |
PRE-EXISTING CONDITION IMPROVED |
3 |
0.0005 |
75 |
AORTIC ARTERIOSCLEROSIS |
1 |
0.0005 |
76 |
VITAMIN B12 DECREASED |
1 |
0.0005 |
77 |
HYPERCHOLESTEROLAEMIA |
3 |
0.0005 |
78 |
RENAL CYST |
3 |
0.0005 |
79 |
LIP PAIN |
1 |
0.0004 |
80 |
MUSCLE STRAIN |
3 |
0.0004 |
81 |
RESPIRATORY RATE INCREASED |
3 |
0.0004 |
82 |
HOSTILITY |
1 |
0.0004 |
83 |
SPINAL OSTEOARTHRITIS |
3 |
0.0004 |
84 |
SPINAL COMPRESSION FRACTURE |
3 |
0.0004 |
85 |
FLANK PAIN |
3 |
0.0004 |
86 |
SPINAL DISORDER |
3 |
0.0004 |
87 |
GINGIVAL BLEEDING |
4 |
0.0004 |
88 |
EXCORIATION |
1 |
0.0004 |
89 |
PLANTAR FASCIITIS |
1 |
0.0004 |
90 |
DECREASED ACTIVITY |
3 |
0.0004 |
91 |
BURSITIS |
3 |
0.0004 |
92 |
ATELECTASIS |
3 |
0.0004 |
93 |
HIATUS HERNIA |
4 |
0.0004 |
94 |
HUNGER |
3 |
0.0004 |
95 |
ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD |
2 |
0.0004 |
96 |
TENDERNESS |
3 |
0.0004 |
97 |
ORAL DISORDER |
2 |
0.0003 |
98 |
ONYCHOMYCOSIS |
1 |
0.0003 |
99 |
NEPHROGENIC SYSTEMIC FIBROSIS |
1 |
0.0003 |
100 |
DENTAL CARIES |
3 |
0.0003 |
101 |
MITRAL VALVE INCOMPETENCE |
3 |
0.0003 |
102 |
PROSTATOMEGALY |
1 |
0.0003 |
103 |
TONGUE DISORDER |
2 |
0.0003 |
104 |
ULCER |
4 |
0.0003 |
105 |
HYPERCALCAEMIA |
3 |
0.0003 |
106 |
TOOTH INFECTION |
3 |
0.0003 |
107 |
SENSORY DISTURBANCE |
4 |
0.0003 |
108 |
ROTATOR CUFF SYNDROME |
3 |
0.0003 |
109 |
PATENT DUCTUS ARTERIOSUS |
1 |
0.0003 |
110 |
OCULAR ICTERUS |
1 |
0.0003 |
111 |
APPLICATION SITE DISCOLOURATION |
1 |
0.0003 |
112 |
PRE-ECLAMPSIA |
1 |
0.0003 |
113 |
MASS |
3 |
0.0003 |
114 |
METASTASES TO BONE |
3 |
0.0003 |
115 |
SKIN TIGHTNESS |
1 |
0.0003 |
116 |
BONE DISORDER |
4 |
0.0003 |
117 |
MUSCULOSKELETAL CHEST PAIN |
3 |
0.0002 |
118 |
PATHOLOGICAL FRACTURE |
1 |
0.0002 |
119 |
VARICOSE VEIN |
1 |
0.0002 |
120 |
MOUTH SWELLING |
1 |
0.0002 |
121 |
BRUXISM |
1 |
0.0002 |
122 |
CHEILITIS |
1 |
0.0002 |
123 |
GINGIVITIS |
1 |
0.0002 |
124 |
TOOTH FRACTURE |
2 |
0.0002 |
125 |
ENTERITIS |
1 |
0.0002 |
126 |
PAIN IN JAW |
5 |
0.0002 |
127 |
LEUKOCYTOSIS |
3 |
0.0002 |
128 |
PIGMENTATION DISORDER |
1 |
0.0002 |
129 |
SKIN MASS |
1 |
0.0002 |
130 |
JAW DISORDER |
1 |
0.0002 |
131 |
APHTHOUS ULCER |
1 |
0.0002 |
132 |
POST-TRAUMATIC STRESS DISORDER |
1 |
0.0002 |
133 |
VENTRICULAR SEPTAL DEFECT |
1 |
0.0002 |
134 |
PREMATURE LABOUR |
1 |
0.0002 |
135 |
LIP DRY |
1 |
0.0002 |
136 |
POLYP |
1 |
0.0002 |
137 |
MUSCLE SPASTICITY |
2 |
0.0002 |
138 |
GLOSSODYNIA |
3 |
0.0002 |
139 |
RIB FRACTURE |
3 |
0.0002 |
140 |
EYE MOVEMENT DISORDER |
1 |
0.0002 |
141 |
MAJOR DEPRESSION |
1 |
0.0002 |
142 |
PRODUCTIVE COUGH |
6 |
0.0002 |
143 |
GENERALISED ERYTHEMA |
1 |
0.0002 |
144 |
APPLICATION SITE VESICLES |
1 |
0.0002 |
145 |
PRODUCT PACKAGING QUANTITY ISSUE |
1 |
0.0002 |
146 |
ABNORMAL FAECES |
1 |
0.0002 |
147 |
SKIN PLAQUE |
1 |
0.0002 |
148 |
SKIN HYPERPIGMENTATION |
1 |
0.0001 |
149 |
ORAL HERPES |
2 |
0.0001 |
150 |
INJECTION SITE DISCOMFORT |
1 |
0.0001 |
151 |
PSYCHOMOTOR HYPERACTIVITY |
2 |
0.0001 |
152 |
OSTEONECROSIS OF JAW |
3 |
0.0001 |
153 |
ATRIAL SEPTAL DEFECT |
1 |
0.0001 |
154 |
CARDIAC MURMUR |
1 |
0.0001 |
155 |
HAEMOPTYSIS |
3 |
0.0001 |
156 |
CARDIOVASCULAR DISORDER |
3 |
0.0001 |
157 |
SALIVARY HYPERSECRETION |
1 |
0.0001 |
158 |
HYPOTHYROIDISM |
3 |
0.0001 |
159 |
HAIR DISORDER |
1 |
0.0001 |
160 |
HAEMORRHOIDS |
2 |
0.0001 |
161 |
ANHEDONIA |
3 |
0.0001 |
162 |
DEFORMITY |
1 |
0.0001 |
163 |
PSYCHOLOGICAL TRAUMA |
1 |
0.0001 |
164 |
OSTEOPOROSIS |
4 |
0.0001 |
165 |
HEPATOMEGALY |
1 |
0.0001 |
166 |
RECTAL HAEMORRHAGE |
4 |
0.0001 |
167 |
STAPHYLOCOCCAL INFECTION |
3 |
0.0001 |
168 |
LUNG DISORDER |
4 |
0.0001 |
169 |
INTERNAL HAEMORRHAGE |
1 |
0.0001 |
170 |
IMPAIRED DRIVING ABILITY |
1 |
0.0001 |
171 |
LOCALISED INFECTION |
2 |
0.0001 |
172 |
MENTAL IMPAIRMENT |
2 |
0.0001 |
173 |
PLASMA CELL MYELOMA |
3 |
0.0001 |
174 |
OXYGEN SATURATION DECREASED |
4 |
0.0001 |
175 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
176 |
BRAIN OEDEMA |
1 |
0.0001 |
177 |
TOOTH EXTRACTION |
1 |
0.0001 |
178 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
179 |
HYPERLIPIDAEMIA |
1 |
0.0001 |
180 |
SKIN ULCER |
2 |
0.0001 |
181 |
MADAROSIS |
1 |
0.0001 |
182 |
CARDIOMEGALY |
1 |
0.0001 |
183 |
PARAESTHESIA ORAL |
1 |
0.0001 |
184 |
PERIPHERAL COLDNESS |
1 |
0.0001 |
185 |
HAIR COLOUR CHANGES |
1 |
0.0001 |
186 |
FEELING COLD |
2 |
0.0001 |
187 |
NEPHROLITHIASIS |
3 |
0.0001 |
188 |
STOMATITIS |
4 |
0.0001 |
189 |
SINUS TACHYCARDIA |
1 |
0.0001 |
190 |
OBESITY |
1 |
0.0001 |
191 |
UPPER RESPIRATORY TRACT INFECTION |
3 |
0.0001 |
192 |
RESPIRATORY TRACT CONGESTION |
1 |
0.0001 |
193 |
PULMONARY OEDEMA |
3 |
0.0001 |
194 |
INTERSTITIAL LUNG DISEASE |
3 |
0.0001 |
195 |
TINNITUS |
3 |
0.0001 |
196 |
HAIR TEXTURE ABNORMAL |
1 |
0.0001 |
197 |
CENTRAL NERVOUS SYSTEM LESION |
1 |
0.0001 |
198 |
COORDINATION ABNORMAL |
1 |
0.0001 |
199 |
PLEURAL EFFUSION |
4 |
0.0001 |
200 |
LYMPHOMA |
1 |
0.0001 |
201 |
HALLUCINATION, AUDITORY |
1 |
0.0001 |
202 |
PREMATURE DELIVERY |
1 |
0.0001 |
203 |
TENDONITIS |
1 |
0.0001 |
204 |
SWELLING FACE |
4 |
0.0001 |
205 |
CYANOSIS |
1 |
0.0001 |
206 |
BONE LOSS |
1 |
0.0001 |
207 |
BLOOD POTASSIUM INCREASED |
1 |
0.0001 |
208 |
MUSCLE TIGHTNESS |
1 |
0.0001 |
209 |
BLOOD GLUCOSE DECREASED |
3 |
0.0001 |
210 |
AMENORRHOEA |
1 |
0.0001 |
211 |
INJECTION SITE HAEMATOMA |
1 |
0.0001 |
212 |
HEMIPARESIS |
1 |
0.0001 |
213 |
CATARACT |
3 |
0.0001 |
214 |
NECK PAIN |
3 |
0.0001 |
215 |
PELVIC PAIN |
1 |
0.0001 |
216 |
CHOKING |
1 |
0.0001 |
217 |
IRRITABLE BOWEL SYNDROME |
1 |
0.0001 |
218 |
GALLBLADDER DISORDER |
1 |
0.0001 |
219 |
INJURY |
4 |
0.0001 |
220 |
SINUS DISORDER |
1 |
0.0001 |
221 |
BLINDNESS |
2 |
0.0001 |
222 |
DISABILITY |
1 |
0.0001 |
223 |
MOUTH ULCERATION |
1 |
0.0001 |
224 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
225 |
FEELING JITTERY |
1 |
0.0001 |
226 |
END STAGE RENAL DISEASE |
1 |
0.0001 |
227 |
HEPATOTOXICITY |
1 |
0.0001 |
228 |
UPPER LIMB FRACTURE |
1 |
0.0001 |
229 |
EATING DISORDER |
1 |
0.0001 |
230 |
BLOOD PRESSURE DECREASED |
3 |
0.0001 |
231 |
LOCAL SWELLING |
1 |
0.0001 |
232 |
PERICARDIAL EFFUSION |
1 |
0.0001 |
233 |
ORAL PAIN |
1 |
0.0001 |
234 |
COGNITIVE DISORDER |
2 |
0.0001 |
235 |
SKIN DISCOLOURATION |
2 |
0.0001 |
236 |
TOOTH DISORDER |
1 |
0.0001 |
237 |
ENCEPHALOPATHY |
1 |
0.0001 |
238 |
CHROMATURIA |
1 |
0.0001 |
239 |
APPLICATION SITE PAIN |
1 |
0.0001 |
240 |
RASH PAPULAR |
1 |
0.0001 |
241 |
RESPIRATORY TRACT INFECTION |
1 |
0.0001 |
242 |
CONVULSION |
3 |
0.0001 |
243 |
WOUND |
1 |
0.0001 |
244 |
RESPIRATORY FAILURE |
3 |
0.0001 |
245 |
ERECTILE DYSFUNCTION |
1 |
0.0001 |
246 |
HYPOAESTHESIA |
6 |
0.0001 |
247 |
BRONCHITIS |
3 |
0.0000 |
248 |
ARTHRITIS |
3 |
0.0000 |
249 |
SEIZURE |
4 |
0.0000 |
250 |
GAIT INABILITY |
1 |
0.0000 |
251 |
UNRESPONSIVE TO STIMULI |
1 |
0.0000 |
252 |
SKIN LESION |
1 |
0.0000 |
253 |
SPEECH DISORDER |
2 |
0.0000 |
254 |
MOOD ALTERED |
1 |
0.0000 |
255 |
PRURITUS GENERALISED |
1 |
0.0000 |
256 |
PAIN OF SKIN |
1 |
0.0000 |
257 |
HYPERSOMNIA |
1 |
0.0000 |
258 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
259 |
NERVOUSNESS |
2 |
0.0000 |
260 |
APPLICATION SITE ERYTHEMA |
1 |
0.0000 |
261 |
DYSSTASIA |
1 |
0.0000 |
262 |
PSYCHOTIC DISORDER |
1 |
0.0000 |
263 |
FEAR |
1 |
0.0000 |
264 |
RESPIRATORY ARREST |
1 |
0.0000 |
265 |
APHASIA |
1 |
0.0000 |
266 |
PREMATURE BABY |
1 |
0.0000 |
267 |
VERTIGO |
2 |
0.0000 |
268 |
SKIN DISORDER |
1 |
0.0000 |
269 |
FEELING HOT |
2 |
0.0000 |
270 |
IMPAIRED HEALING |
1 |
0.0000 |
271 |
SLEEP DISORDER |
2 |
0.0000 |
272 |
ASTHMA |
3 |
0.0000 |
273 |
HEART RATE INCREASED |
3 |
0.0000 |
274 |
FUNGAL INFECTION |
1 |
0.0000 |
275 |
RASH MACULAR |
1 |
0.0000 |
276 |
TARDIVE DYSKINESIA |
1 |
0.0000 |
277 |
PHARMACEUTICAL PRODUCT COMPLAINT |
1 |
0.0000 |
278 |
LIP SWELLING |
1 |
0.0000 |
279 |
CHOLELITHIASIS |
1 |
0.0000 |
280 |
ABDOMINAL DISTENSION |
3 |
0.0000 |
281 |
CONSTIPATION |
6 |
0.0000 |
282 |
AMNESIA |
2 |
0.0000 |
283 |
INJECTION SITE MASS |
1 |
0.0000 |
284 |
HYPERKALAEMIA |
1 |
0.0000 |
285 |
HAEMOGLOBIN DECREASED |
3 |
0.0000 |
286 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
287 |
HALLUCINATION |
2 |
0.0000 |
288 |
NO ADVERSE EVENT |
4 |
0.0000 |
289 |
HEART RATE DECREASED |
1 |
0.0000 |
290 |
EYE SWELLING |
1 |
0.0000 |
291 |
GYNAECOMASTIA |
1 |
0.0000 |
292 |
ANXIETY |
8 |
0.0000 |
293 |
MATERNAL EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
294 |
JOINT SWELLING |
3 |
0.0000 |
295 |
ADVERSE DRUG REACTION |
2 |
0.0000 |
296 |
DRY MOUTH |
2 |
0.0000 |
297 |
CRYING |
1 |
0.0000 |
298 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
299 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
300 |
DISORIENTATION |
1 |
0.0000 |
301 |
INTENTIONAL PRODUCT MISUSE |
2 |
0.0000 |
302 |
THROAT IRRITATION |
1 |
0.0000 |
303 |
TREMOR |
4 |
0.0000 |
304 |
MUSCULOSKELETAL STIFFNESS |
2 |
0.0000 |
305 |
LOSS OF CONSCIOUSNESS |
3 |
0.0000 |
306 |
MENTAL DISORDER |
1 |
0.0000 |
307 |
COUGH |
6 |
0.0000 |
308 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
309 |
HYPERHIDROSIS |
3 |
0.0000 |
310 |
OROPHARYNGEAL PAIN |
2 |
0.0000 |
311 |
PAIN |
14 |
0.0000 |
312 |
HYPOKALAEMIA |
1 |
0.0000 |
313 |
CEREBROVASCULAR ACCIDENT |
4 |
0.0000 |
314 |
SWELLING |
2 |
0.0000 |
315 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
1 |
0.0000 |
316 |
HYPERSENSITIVITY |
4 |
0.0000 |
317 |
RENAL DISORDER |
1 |
0.0000 |
318 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
319 |
CHEST PAIN |
4 |
0.0000 |
320 |
SKIN IRRITATION |
1 |
0.0000 |
321 |
DEPRESSION |
5 |
0.0000 |
322 |
COMA |
1 |
0.0000 |
323 |
CARDIAC DISORDER |
2 |
0.0000 |
324 |
MULTIPLE SCLEROSIS |
1 |
0.0000 |
325 |
SURGERY |
1 |
0.0000 |
326 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
327 |
FEELING ABNORMAL |
5 |
0.0000 |
328 |
BLOOD PRESSURE INCREASED |
3 |
0.0000 |
329 |
VOMITING |
9 |
0.0000 |
330 |
RASH PRURITIC |
1 |
0.0000 |
331 |
SYNCOPE |
2 |
0.0000 |
332 |
DRUG INEFFECTIVE |
25 |
0.0000 |
333 |
FLUID RETENTION |
1 |
0.0000 |
334 |
PLATELET COUNT DECREASED |
2 |
0.0000 |
335 |
HYPERTENSION |
4 |
0.0000 |
336 |
PANCREATITIS |
1 |
0.0000 |
337 |
INSOMNIA |
5 |
0.0000 |
338 |
FLATULENCE |
1 |
0.0000 |
339 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
340 |
DYSPHONIA |
1 |
0.0000 |
341 |
NASOPHARYNGITIS |
3 |
0.0000 |
342 |
ABDOMINAL PAIN |
4 |
0.0000 |
343 |
SUICIDE ATTEMPT |
1 |
0.0000 |
344 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
345 |
PNEUMONIA |
5 |
0.0000 |
346 |
DIZZINESS |
8 |
0.0000 |
347 |
HYPOTENSION |
3 |
0.0000 |
348 |
SOMNOLENCE |
3 |
0.0000 |
349 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
350 |
FATIGUE |
11 |
0.0000 |
351 |
DEHYDRATION |
2 |
0.0000 |
352 |
ERYTHEMA |
3 |
0.0000 |
353 |
INJECTION SITE REACTION |
1 |
0.0000 |
354 |
STRESS |
1 |
0.0000 |
355 |
MOBILITY DECREASED |
1 |
0.0000 |
356 |
DYSPNOEA |
8 |
0.0000 |
357 |
ACUTE KIDNEY INJURY |
2 |
0.0000 |
358 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
359 |
RENAL FAILURE |
2 |
0.0000 |
360 |
DECREASED APPETITE |
3 |
0.0000 |
361 |
SKIN BURNING SENSATION |
1 |
0.0000 |
362 |
INJECTION SITE BRUISING |
1 |
0.0000 |
363 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
364 |
EPISTAXIS |
1 |
0.0000 |
365 |
SKIN EXFOLIATION |
1 |
0.0000 |
366 |
FOETAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
367 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
368 |
DYSGEUSIA |
1 |
0.0000 |
369 |
CARDIAC FAILURE |
1 |
0.0000 |
370 |
DIABETES MELLITUS |
1 |
0.0000 |
371 |
CONFUSIONAL STATE |
2 |
0.0000 |
372 |
PRODUCT DOSE OMISSION |
1 |
0.0000 |
373 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
374 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
375 |
BALANCE DISORDER |
1 |
0.0000 |
376 |
MIGRAINE |
1 |
0.0000 |
377 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
0.0000 |
378 |
CONTUSION |
1 |
0.0000 |
379 |
ARTHRALGIA |
4 |
0.0000 |
380 |
PAIN IN EXTREMITY |
3 |
0.0000 |
381 |
HAEMORRHAGE |
1 |
0.0000 |
382 |
RASH |
4 |
0.0000 |
383 |
DRUG WITHDRAWAL SYNDROME |
1 |
0.0000 |
384 |
FALL |
3 |
0.0000 |
385 |
NAUSEA |
7 |
0.0000 |
386 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
387 |
BACK PAIN |
2 |
0.0000 |
388 |
CHILLS |
1 |
0.0000 |
389 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
390 |
DRY SKIN |
1 |
0.0000 |
391 |
COVID-19 |
1 |
0.0000 |
392 |
CONDITION AGGRAVATED |
2 |
0.0000 |
393 |
INJECTION SITE PAIN |
2 |
0.0000 |
394 |
WEIGHT DECREASED |
2 |
0.0000 |
395 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
396 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
397 |
HEADACHE |
4 |
0.0000 |
398 |
URTICARIA |
1 |
0.0000 |
399 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
400 |
DRUG INTERACTION |
1 |
0.0000 |
401 |
URINARY TRACT INFECTION |
1 |
0.0000 |
402 |
PARAESTHESIA |
1 |
0.0000 |
403 |
PRURITUS |
2 |
0.0000 |
404 |
MYALGIA |
1 |
0.0000 |
405 |
PRODUCT USE ISSUE |
1 |
0.0000 |
406 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
407 |
ASTHENIA |
2 |
0.0000 |
408 |
DRUG DEPENDENCE |
1 |
0.0000 |
409 |
ANAEMIA |
1 |
0.0000 |
410 |
GAIT DISTURBANCE |
1 |
0.0000 |
411 |
DRUG HYPERSENSITIVITY |
1 |
0.0000 |
412 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
413 |
ALOPECIA |
1 |
0.0000 |
414 |
DIARRHOEA |
3 |
0.0000 |
415 |
DRUG DOSE OMISSION |
1 |
0.0000 |
416 |
OVERDOSE |
1 |
0.0000 |
417 |
DEATH |
2 |
0.0000 |
418 |
OFF LABEL USE |
1 |
0.0000 |